1,463
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Human neutrophil elastase inhibitory potential of flavonoids from Campylotropis hirtella and their kinetics

, , , , , , & show all
Pages 16-22 | Received 31 Jul 2015, Accepted 16 Oct 2015, Published online: 25 Aug 2016
 

Abstract

Campylotropis hirtella is used as a food supplement in the subtropical region of China. In an intensive hunt for human neutrophil elastase inhibitors, we isolated eight flavonoids from C. hirtella three of which (13) emerged to be elastase inhibitors. Geranylated flavonoids (13) displayed significant inhibitory activity with IC50s between 8.5 and 30.8 μM. The most striking example was geranylated isofavanone 3 that inhibited elastase significantly (IC50 =30.8 μM) but its parent compound (dalbergioidin) and isoflavone analog (5) were inactive (IC50 >200 μM). Compounds (13) displayed different kinetic mechanisms (noncompetitive, competitive, and mixed type, respectively) that were dependent upon the parent skeleton. The competitive inhibitor, isoflavan-3-ol-4-one 2 manifested an inhibition of isomerization profile for elastase with kinetic parameters K5 =0.0386 M−1S−1, K6 =0.0244 μM−1S−1 and Kiapp = 16.3427 μM. The specific identification of metabolites was accomplished by LC-DAD-ESI/MS that was also used to analyze abundance of active components (13) within the plant.

Declaration of interest

The authors declared that there are not conflicts of interest. The research was supported by a grant Next-Generation BioGreen 21 program (SSAC, NO. PJ01107001), Rural development Administration, Republic of Korea. All students were supported by a scholarship from the BK21 plus program.

Supplementary material available online

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.